Rongwen Bian

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 316 citations

Metabolic Syndrome, Glucose Tolerance, Diabetes Management +10

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

Roseanne O. Yeung, Yuying Zhang, Andrea O. Y. Luk et al. · The Lancet Diabetes & Endocrinology · 2014 · 291 citations

Obesity, Metabolic Syndrome, Diabetes Management +10

Cardiovascular Diseases and Risk‐Factor Burden in Urban and Rural Communities in High‐, Middle‐, and Low‐Income Regions of China: A Large Community‐Based Epidemiological Study

Ruohua Yan, Li Wei, Yin Lu et al. · Journal of the American Heart Association · 2017 · 110 citations · Full text

Predictive Values of Anthropometric Measurements for Cardiometabolic Risk Factors and Cardiovascular Diseases Among 44 048 Chinese

Jia Liu, Lap Ah Tse, Zhiguang Liu et al. · Journal of the American Heart Association · 2019 · 109 citations · Full text

Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function

Liubao Gu, Liji Huang, Haidi Wu et al. · Diabetes and Vascular Disease Research · 2017 · 85 citations · Full text